As the first Sino-foreign joint venture large scale blood product producer established in 1988, Shanghai Raas is the first enterprise realized batch production of blood products and passed certification of ISO9001 quality system, and it’s among the first batch of enterprises passed GMP certification. The company is mainly engaged in the production and sales of blood products, vaccines, diagnostic reagents, testing instruments, testing technology and testing service pursuant to rules of FDA, guidelines of WHO as well as requirements of United States Pharmacopeia and European Pharmacopoeia. Its main products include 7 varieties and 23 specifications, such as human serum albumin, human immunoglobulin (pH4) for intravenous injection, human coagulation factor VIII, human prothrombin complex, human fibrinogen, thrombin and etc. It’s a leading blood product producer among its peers in China which characterized by the highest comprehensive utilization of blood plasma, most complete product varieties and rational structure. Given its extraordinary product quality and advanced technologies, Shanghai Raas has become one of the most famous blood product enterprises in China and even Asia. Its products have been dominating the high-end market for China’s blood product consumption, which gave it excellent brand awareness in the industry and among consumers. It’s the first one explored overseas market in China, and the blood product producer with the largest export volume. Shanghai Raas transformed into a limited liability company in March 2007, and listed in Shenzhen Stock Exchange（SZ002252） in June 2008.